Nine years of experience in the field of molecular biology and computational biology. Poulami's PhD was focused on peptide-based vectors for siRNA delivery for cancer and gene discovery and her Post Doc explored pre-mRNA splicing mechanisms and their role in disease manifestation, especially in disease areas like Duchenne Muscular Dystrophy. She holds multiple patents for her algorithms and concepts concerning splicing score-based disease understanding and DNA computing. Poulami worked as a lead scientist for TCS Innovation Labs for six years. She founded Helex bringing her knowledge of the non-coding DNA, 3D genome, and experience with computational biology to fill in the much-needed gap of intelligently understanding gene editing and solving for diseases.

Anirudh brings over ten years of experience in operations and sales in life sciences. He has established a formulations’ vertical from scratch for a mid-sized pharmaceutical company and has led its sales to over $15 million with a future pipeline of over $25 million. He has experience in taking formulations through various regulatory applications across U.S FDA, Europe’s EMA, U.K’s MHRA and others.

Nine years of healthcare consulting, strategy and business development experience. Rohini has worked extensively with U.S healthcare systems, both providers and payors, to expand the use of capitation payment models of insurance. As a previous VP of Strategy at a chronic care management company, she was responsible for sixty percent of growth with two new product lines for B2B and B2G growth modalities. Prior to that, Rohini led programs to strengthen Public Private Partnerships in healthcare to improve access to services, and maintain high quality of healthcare services in developing countries funded by the Bill and Melinda Gates Foundation, The World Bank amongst many others.

Ten years experience in product engineering, process engineering, AI/ ML Rakesh brings significant experience of building scalable technologies that have deep impact in the Fintech space with J.P. Morgan Chase. He is adept in conceptualizing business and technology needs, planning and executing, integrating AI/ML and data analytics to augment performance. Rakesh also brings significant management experience having coached, trained and managed technology teams and external vendors.

Five years of experience in genome editing, delivery of genome editing material. Neha brings significant experience in genome editing, in developing proprietary molecular nanomachines for intracellular delivery of genomic materials. She has significant experience in leading programs from scientific conceptualisation, pilot testing to executing proof of concept and pre-clinical studies.

Harsha comes with an extensive background in working on ocular diseases, particularly working on novel delivery mechanisms to successfully reach various types of cell types in the eye. She has extensive experience with various cell lines and the murine model of infectious keratitis. At Helex, Harsha contributes to our pre-clinical work and translational R&D.